Follow
Kok Pin Ng
Kok Pin Ng
National Neuroscience Institute
Verified email at singhealth.com.sg
Title
Cited by
Cited by
Year
Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
KP Ng, TA Pascoal, S Mathotaarachchi, J Therriault, MS Kang, M Shin, ...
Alzheimer's research & therapy 9, 1-9, 2017
3522017
In vivo quantification of neurofibrillary tangles with [18F]MK-6240
TA Pascoal, M Shin, MS Kang, M Chamoun, D Chartrand, ...
Alzheimer's research & therapy 10, 1-14, 2018
1672018
Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer’s disease
H Zhang, J Therriault, MS Kang, KP Ng, TA Pascoal, P Rosa-Neto, ...
Alzheimer's research & therapy 10, 1-11, 2018
912018
Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease
KP Ng, TA Pascoal, S Mathotaarachchi, CO Chung, AL Benedet, M Shin, ...
Neurology 88 (19), 1814-1821, 2017
882017
Anosognosia predicts default mode network hypometabolism and clinical progression to dementia
J Therriault, KP Ng, TA Pascoal, S Mathotaarachchi, MS Kang, H Struyfs, ...
Neurology 90 (11), e932-e939, 2018
752018
Associations of AT (N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
KP Ng, H Chiew, P Rosa-Neto, N Kandiah, Z Ismail, S Gauthier
Translational Neurodegeneration 10, 1-14, 2021
522021
The influence of language and culture on cognitive assessment tools in the diagnosis of early cognitive impairment and dementia
KP Ng, HJ Chiew, L Lim, P Rosa-Neto, N Kandiah, S Gauthier
Expert review of neurotherapeutics 18 (11), 859-869, 2018
512018
Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease
H Zhang, KP Ng, J Therriault, MS Kang, TA Pascoal, P Rosa-Neto, ...
Translational neurodegeneration 7, 1-12, 2018
502018
Impact of the biological definition of Alzheimer’s disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body …
S Gauthier, H Zhang, KP Ng, TA Pascoal, P Rosa-Neto
Translational neurodegeneration 7, 1-7, 2018
502018
The use of tau PET to stage Alzheimer disease according to the Braak staging framework
AC Macedo, C Tissot, J Therriault, S Servaes, YT Wang, ...
Journal of Nuclear Medicine 64 (8), 1171-1178, 2023
382023
Agitation and impulsivity in mid and late life as possible risk markers for incident dementia
DR Bateman, S Gill, S Hu, ED Foster, MT Ruthirakuhan, AF Sellek, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 6 (1 …, 2020
382020
Cerebral small vessel disease influences hippocampal subfield atrophy in mild cognitive impairment
FCC Wong, C Yatawara, A Low, H Foo, BYX Wong, L Lim, B Wang, ...
Translational Stroke Research 12, 284-292, 2021
352021
Age moderates associations of hypertension, white matter hyperintensities, and cognition
AC Guevarra, SC Ng, SE Saffari, BYX Wong, RJ Chander, KP Ng, ...
Journal of Alzheimer's Disease 75 (4), 1351-1360, 2020
302020
Associations between lesions and domain-specific cognitive decline in poststroke dementia
C Yatawara, KP Ng, R Chander, N Kandiah
Neurology 91 (1), e45-e54, 2018
302018
Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer’s disease?
M Ba, M Kong, X Li, KP Ng, P Rosa-Neto, S Gauthier
Translational Neurodegeneration 5, 1-4, 2016
292016
Brain metabolic dysfunction in early neuropsychiatric symptoms of dementia
KP Ng, HJ Chiew, P Rosa-Neto, N Kandiah, Z Ismail, S Gauthier
Frontiers in Pharmacology 10, 1398, 2019
282019
Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [18F] THK5351 uptake in progressive supranuclear palsy
KP Ng, J Therriault, MS Kang, H Struyfs, TA Pascoal, S Mathotaarachchi, ...
NeuroImage: Clinical 24, 102091, 2019
282019
[11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer’s disease
TA Pascoal, M Chamoun, E Lax, HY Wey, M Shin, KP Ng, MS Kang, ...
nature communications 13 (1), 4171, 2022
252022
The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
M Ba, X Li, KP Ng, TA Pascoal, S Mathotaarachchi, P Rosa-Neto, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 3 (1 …, 2017
202017
Neuropsychiatric correlates of small vessel disease progression in incident cognitive decline: independent and interactive effects
CN Kan, B Gyanwali, S Hilal, KP Ng, N Venketasubramanian, CLH Chen, ...
Journal of Alzheimer's Disease 73 (3), 1053-1062, 2020
182020
The system can't perform the operation now. Try again later.
Articles 1–20